A Prospective, Multicenter Observational Study on MAST™ (Minimal Access Spinal Technologies) Fusion Procedures for the Treatment of the Degenerative Lumbar Spine

NCT ID: NCT01143324

Last Updated: 2019-01-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

255 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-06-30

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to observe and document surgical practice and evaluate patients' outcomes following a MAST™ single or double level instrumented fusion procedure using PLIF (Posterior Lumbar Interbody Fusion) or TLIF (Transforaminal Lumbar Interbody Fusion) techniques for the treatment of the degenerative lumbar spine in a "real-world" patient population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Instrumented lumbar fusion is usually done through an open procedure which involves an excessive intraoperative dissection and retraction of the paraspinal musculature leading, in a short term basis, to a prolonged recovery time from the surgery. This open approach is frequently associated with significant blood loss and need of transfusion, produces the majority of the perioperative pain, increases hospital stay and the chances of infection and delays the return to normal activities and to work. In a long term basis, the open procedure leads to denervation, atrophy and loss of the muscles independent function, resulting in an increased risk of "fusion disease", a term that has been coined to describe its occurrence.

The minimally invasive spinal surgery was developed as a potential solution to the above-mentioned problems by reducing the amount of iatrogenic soft tissue injury while reaching the same traditional goals of the open procedures. Besides minimizing the long-term effects of exposure-related muscle injury, minimally invasive lumbar fusion techniques hold the promise of immediate short-term advantages. Patients undergoing minimally invasive procedures are reported to recover earlier from the surgery. Shorter time to first ambulation, less pain medication consumption, less blood loss, less required transfusion, shorter hospital stay and earlier return to work are generally associated with the minimally invasive procedure as compared to the standard open surgeries. The minimally invasive access requires a surgical corridor targeted on the disease which is accomplished by using a series of tubular muscle dilators allowing a clear intraoperative visualization to perform these procedures together with the parallel use of image guided percutaneous insertion of pedicle screws and instrumentation.

The purpose of this study is to observe and document surgical practice and evaluate patients' outcomes following a MAST™ single or double level instrumented fusion procedure using PLIF or TLIF techniques for the treatment of the degenerative lumbar spine in a "real-world" patient population.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Degenerative Lumbar Spine Causing Back and/or Leg Pain Lumbar Spine Degeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MAST™ procedure

MAST™ procedure

Intervention Type DEVICE

Single or double level instrumented fusion receiving the CD Horizon® Spinal System using PLIF or TLIF techniques via a MAST™ procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MAST™ procedure

Single or double level instrumented fusion receiving the CD Horizon® Spinal System using PLIF or TLIF techniques via a MAST™ procedure.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is \>18 years of age (or minimum age as required by local regulations).
* Patient has indication for a single or double level instrumented lumbar fusion for the treatment of the degenerative lumbar spine.
* Patient agrees to participate in the study and is able to sign the Data Release Form/Informed Consent.
* The procedure planned for the patient complies with the labeling of the Devices that may be used in the surgical procedure as described in the section B.2 Device Information.
* Patient is planned to be submitted to the fusion procedure using PLIF or TLIF techniques and to receive a CD HORIZON® Spinal System via a MAST™ approach.
* The patient is willing and is able to cooperate with study procedures and required follow-up visits.

Exclusion Criteria

* Patient that has already undergone an open lumbar spine surgery other than microdiscectomy.
* Indications for the procedure other than degenerative spine disease like Osteoporotic vertebral fractures, Spine trauma fractures and Spine tumor.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic Spinal and Biologics

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jörg Franke, PD Dr.

Role: PRINCIPAL_INVESTIGATOR

Klinik für Wirbelsäulenchirurgie; Dortmund

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinikum Amstetten

Amstetten, , Austria

Site Status

OLV Ziekenhuis

Aalst, , Belgium

Site Status

Spine, Sports Medicine and Orthopedic Surgery

Saint John, New Brunswick, Canada

Site Status

Karvinska Hornicka Nemocnice

Fryštát, , Czechia

Site Status

Klinikum Kulmbach

Kulmbach, Bavaria, Germany

Site Status

Marienhaus Klinikum

Bendorf, , Germany

Site Status

Neurochirurgische Universitatsklinik

Freiburg im Breisgau, , Germany

Site Status

Universitätsklinikum Magdeburg

Magdeburg, , Germany

Site Status

Mediterraneo

Glyfada, , Greece

Site Status

The Tel Aviv Sourasky Medical Center

Tel Aviv, , Israel

Site Status

Instituto Ortopedici Rizzoli

Bologna, , Italy

Site Status

Fatebenefratelli Hospital

Milan, , Italy

Site Status

Bergman Clinics

Naarden, , Netherlands

Site Status

Franciscus Ziekenhuis Roosendaal

Roosendaal, , Netherlands

Site Status

University Clinical Center

Gdansk, , Poland

Site Status

Hospital San Joao

Porto, , Portugal

Site Status

Ustredna Vojenska Nemocnica SNP

Ružomberok, , Slovakia

Site Status

Hospital Clinic De Barcelona

Barcelona, , Spain

Site Status

Guys & St; Thomas NHS Trust

London, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Belgium Canada Czechia Germany Greece Israel Italy Netherlands Poland Portugal Slovakia Spain United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MASTERS-D Study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

OLIF25™ /OLIF51™ Study
NCT02657421 TERMINATED